Skip to main content
. 2020 Oct 23;99(43):e22679. doi: 10.1097/MD.0000000000022679

Figure 1.

Figure 1

Serum IL-1β level in the GDM patients and healthy controls. The serum IL-1β levels in GDM patients are significantly higher than those of healthy controls (n = 23/group, P = .023). These data indicate that the serum IL-1β level is involved in the occurrence and development of GDM (P < .05, GDM vs Control).